Logo image of CORZ

CORE SCIENTIFIC INC (CORZ) Stock Fundamental Analysis

NASDAQ:CORZ - Nasdaq - US21874A1060 - Common Stock - Currency: USD

13.56  +1.05 (+8.39%)

Premarket: 13.88 +0.32 (+2.36%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CORZ. CORZ was compared to 282 industry peers in the Software industry. While CORZ seems to be doing ok healthwise, there are quite some concerns on its profitability. CORZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CORZ has reported negative net income.
CORZ had a negative operating cash flow in the past year.
In the past 5 years CORZ reported 4 times negative net income.
In multiple years CORZ reported negative operating cash flow during the last 5 years.
CORZ Yearly Net Income VS EBIT VS OCF VS FCFCORZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

With a Return On Assets value of -54.13%, CORZ is not doing good in the industry: 85.82% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -54.13%
ROE N/A
ROIC N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CORZ Yearly ROA, ROE, ROICCORZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

CORZ has a Gross Margin of 12.57%. This is amonst the worse of the industry: CORZ underperforms 85.46% of its industry peers.
In the last couple of years the Gross Margin of CORZ has grown nicely.
CORZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
CORZ Yearly Profit, Operating, Gross MarginsCORZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

CORZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
CORZ has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CORZ has less shares outstanding
The debt/assets ratio for CORZ has been reduced compared to a year ago.
CORZ Yearly Shares OutstandingCORZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CORZ Yearly Total Debt VS Total AssetsCORZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CORZ has an Altman-Z score of -0.85. This is a bad value and indicates that CORZ is not financially healthy and even has some risk of bankruptcy.
CORZ's Altman-Z score of -0.85 is on the low side compared to the rest of the industry. CORZ is outperformed by 75.18% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.85
ROIC/WACCN/A
WACC10.1%
CORZ Yearly LT Debt VS Equity VS FCFCORZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

CORZ has a Current Ratio of 4.26. This indicates that CORZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.26, CORZ belongs to the best of the industry, outperforming 84.75% of the companies in the same industry.
A Quick Ratio of 4.26 indicates that CORZ has no problem at all paying its short term obligations.
The Quick ratio of CORZ (4.26) is better than 85.11% of its industry peers.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 4.26
CORZ Yearly Current Assets VS Current LiabilitesCORZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CORZ have decreased strongly by -2858.82% in the last year.
CORZ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.76%.
Measured over the past years, CORZ shows a very strong growth in Revenue. The Revenue has been growing by 53.71% on average per year.
EPS 1Y (TTM)-2858.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%681.25%
Revenue 1Y (TTM)-26.76%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-55.64%

3.2 Future

The Earnings Per Share is expected to grow by 27.84% on average over the next years. This is a very strong growth
Based on estimates for the next years, CORZ will show a very strong growth in Revenue. The Revenue will grow by 32.74% on average per year.
EPS Next Y119.12%
EPS Next 2Y43.44%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue Next Year-19.53%
Revenue Next 2Y28.96%
Revenue Next 3Y31.59%
Revenue Next 5Y32.74%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CORZ Yearly Revenue VS EstimatesCORZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
CORZ Yearly EPS VS EstimatesCORZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CORZ. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 38.44, the valuation of CORZ can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CORZ is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CORZ to the average of the S&P500 Index (35.58), we can say CORZ is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 38.44
CORZ Price Earnings VS Forward Price EarningsCORZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CORZ Per share dataCORZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CORZ's earnings are expected to grow with 27.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.44%
EPS Next 3Y27.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CORZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE SCIENTIFIC INC

NASDAQ:CORZ (7/14/2025, 8:00:01 PM)

Premarket: 13.88 +0.32 (+2.36%)

13.56

+1.05 (+8.39%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-07 2025-08-07
Inst Owners81.81%
Inst Owner Change0%
Ins Owners3.22%
Ins Owner Change1.99%
Market Cap4.12B
Analysts85
Price Target18.45 (36.06%)
Short Float %18.48%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)326.79%
Min EPS beat(2)-602.54%
Max EPS beat(2)1256.12%
EPS beat(4)1
Avg EPS beat(4)-3604.56%
Min EPS beat(4)-13917.4%
Max EPS beat(4)1256.12%
EPS beat(8)3
Avg EPS beat(8)-1895.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.56%
Min Revenue beat(2)-12.25%
Max Revenue beat(2)-6.86%
Revenue beat(4)1
Avg Revenue beat(4)-5.06%
Min Revenue beat(4)-12.25%
Max Revenue beat(4)7.59%
Revenue beat(8)3
Avg Revenue beat(8)-5.97%
Revenue beat(12)4
Avg Revenue beat(12)-5.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.65%
PT rev (3m)-7.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.03%
EPS NY rev (1m)596.79%
EPS NY rev (3m)3543.83%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)-23.76%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-15.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 38.44
P/S 10.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.03
EYN/A
EPS(NY)0.35
Fwd EY2.6%
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS1.35
BVpS-0.6
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.57%
FCFM N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.97%
Cap/Sales 36.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.26
Quick Ratio 4.26
Altman-Z -0.85
F-Score3
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)122.96%
Cap/Depr(5y)360.66%
Cap/Sales(3y)38.66%
Cap/Sales(5y)43.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2858.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%681.25%
EPS Next Y119.12%
EPS Next 2Y43.44%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.76%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-55.64%
Revenue Next Year-19.53%
Revenue Next 2Y28.96%
Revenue Next 3Y31.59%
Revenue Next 5Y32.74%
EBIT growth 1Y-261.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year695.13%
EBIT Next 3Y204.88%
EBIT Next 5Y188.87%
FCF growth 1Y-62.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.69%
OCF growth 3YN/A
OCF growth 5YN/A